Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

GLP-1s, the popular medications helping millions of people lose weight by curbing their appetites, may not be very high on the list of things ... Circana found that GLP-1 users traditionally ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as GLP-1 receptor agonists, including the popular name brands Ozempic ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...

Ezekiel Emanuel and Dr. Ty Gluckman explore trends in patients stopping or restarting GLP-1 medications. This graph shows the time to discontinuation and reinitiation for patients with and without ...

Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for alternative ways to administer anti-obesity drugs. The new, compounded offering ...